Previous
Previous

Lennham publishes manuscript detailing the nonclinical PK and safety evaluation of d9-caffeine in Food and Chemical Toxicology

Next
Next

Lennham Pharmaceuticals Expands Leading Psilocybin Patent Portfolio with Addition of New Patent Family